Table 1.
Cross-sectional and longitudinal studies based on databases or surveys | |||||
---|---|---|---|---|---|
Authors | Database and sample size | Alzheimer’s disease diagnosis or parameters | Periodontal disease diagnosis or parameters | Outcomes | |
Beydounet al. (2021)45 | NHANES (1988–1991) 1439 American patients
|
Diagnosis:
|
Parameters:
Two sites on every tooth in 2 quadrants |
|
|
Yu et al. (2008) 28 | NHANES (2001–2002) 803 dentate American patients
|
Parameters recorded:
|
Diagnosis:
|
|
|
Beydoun et al. (2020) 44 | NHANES (1988–1994) linked with National Death Index and Medicare data (2014) 6650 American patients
|
Diagnosis:
|
Parameters recorded:
|
AD incident risk
|
Inverse AD incident risk+
|
Chen et al. (2017) 27 | National Health Insurance Research Database (1996–2013) 27963 Taiwanese patients
|
Diagnosis:
|
Diagnosis:
|
|
|
Noble et al. (2009) 46 | NHANES (1988–1994) 2355 American patients
|
Diagnosis:
|
Parameters:
|
|
|
Noble et al. (2014) 47 | Washington Heights-Inwood Columbia Aging Project 219 American patients
|
Not mentioned | Parameters: Serum IgG antibody against - P. gingivalis
|
|
AD and periodontal clinical parameters in cross-sectional and cohort studies | ||||
---|---|---|---|---|
Authors | Sample size | AD diagnosis or parameters | Periodontal disease diagnosis or parameters | Outcomes |
Iwasaki et al. (2015) 63 | 291 Japanese patients (101 males/190 females)
|
Diagnosis:
|
Diagnosis:
|
Periodontal disease and edentulism were significantly associated with greater odds of low cognitive performance after controlling for potential confounders. |
Moriya et al. (2012) 50 | 152 Japanese patients Inclusion criteria:
|
Parameters
|
Diagnosis:
|
Weak but statistically significant negative correlations were established between the RCPM test, the VerPA task, and the VisPA task and periodontal status, but not the Block Design Test. |
Kaye et al. (2013) 48 | 597 dentate American patients
|
Low cognitive statuses:
|
Parameters:
|
|
Iwasaki et al. (2016) 64 | 85 Japanese patients
|
Parameters
|
Diagnosis: Severe periodontitis:
|
|
Kamer et al. (2012) 49 | 152 Danish patients
|
Parameters:
|
Diagnosis
Parameters:
|
|
Clinical studies on AD and inflammatory markers or IgG | |||||||
---|---|---|---|---|---|---|---|
Authors | Sample size | Alzheimer’s disease diagnosis or parameters | Periodontal disease diagnosis or parameters | Serology sampling site | Inflammatory markers | IgG | Outcomes |
Sochocka et al. (2017) 51 | 128 Polish patients (45 males/83 females)
|
Diagnosis:
|
Parameters:
|
Sampling:
|
Inflammatory markers:
|
Not mentioned |
|
Kamer et al. (2009) 52 | 34 American patients
|
Parameters:
|
Not mentioned | Sampling:
|
Inflammatory markers:
|
IgG against - A. actinomycetemcomitans serotype b (ATCC 43718),
|
|
Ide et al. (2016) 53 | 59 English patients (30 males/29 females)
|
Parameters:
|
Diagnosis:
|
Sampling:
|
Inflammatory markers:
|
IgG against P. gingivalis |
|
Stein et al. (2012) 54 | 158 American patients
72.1 years (MCI) 74.1 years (AD)
|
Diagnosis:
|
Not mentioned | Sampling:
|
Not mentioned | IgG against - A. actinomycetemcomitans
|
|
Studies on AD and the oral microbiome using PCR | ||||||
---|---|---|---|---|---|---|
Authors | Sample size | Alzheimer’s disease diagnosis or parameters | Periodontal disease diagnosis or parameters | AD markers | Microbiology | Outcomes |
Leblhuber et al. (2020) 55 | 20 Austrian patients (11 males/9 females)
|
Parameters:
|
Not mentioned |
|
Sampling site:
|
|
Laugisch et al. (2018) 56 | 40 German patients
|
Diagnosis:
|
Diagnosis:
|
|
Sampling site:
|
|
Studies on AD and the oral microbiome using NGS or the third-generation technique | |||||||
---|---|---|---|---|---|---|---|
Authors | Sample size | Alzheimer’s disease diagnosis or parameters | Periodontal disease diagnosis or parameters | AD markers | Microbiology sampling site and method | Outcomes | |
Holmer et al. (2021)57 | 195 Swedish patients
|
Diagnosis:
|
Diagnosis:
|
Not mentioned | Sampling site:
|
|
|
More abundant in AD group
|
More abundant in controls
|
||||||
Wu et al. (2021) 59 | 35 Taiwanese patients
|
Parameters:
|
Not mentioned | Not mentioned | Sampling site:
|
Overall oral microbial diversity in the AD group tended to be lower than that in the control group. | |
More abundant in AD group Order:
|
More abundant in controls Order:
|
||||||
Yang et al. (2021) 58 | 68 older American patients (27 males/41 females)
|
Diagnosis
|
Not mentioned | Sampling site:
|
Sampling site:
|
|
|
More abundant in AD group
|
More abundant in controls
|
||||||
Liu et al. (2019) 60 | 78 Chinese patients (39 males/39 females)
|
Diagnosis:
|
Not mentioned |
|
Sampling site:
|
|
|
- | More abundant in AD group Genus:
|
More abundant in controls
|
| ||||
---|---|---|---|---|
Authors | Sample size | Microbiology sampling site and method | Outcomes | |
Emery et al. (2017) 61 | 26 patients
|
Sampling site: Temporal cortex Right hemispheres:
|
|
|
More abundant in AD group
|
More abundant in controls
|
|||
Siddiqui et al. (2019) 62 |
|
Sampling site:
|
|
|
More abundant in AD group Phylum
|
More abundant in controls Phylum
|
|||
Dominy et al. (2019) 30 | 58 patients
|
Sampling site
|
|
|
More abundant in AD group
|
More abundant in controls | |||
Poole et al. (2013) 31 | 20 patients
|
Sampling site:
|
|
|
Riviere et al. (2002) 32 | Group 1
|
Group 3
33 living patients
|
Sampling site:
|
|
Amyloid β plaques (Aβ), Attachment loss (AL), Apolipoprotein E (APOE), Approximal plaque index (API), Bleeding on probing (BoP), Block Design Test (BDT), Clinical attachment level (CAL), Chronic periodontitis (CP), Cerebrospinal fluid (CSF), Hasegawa Dementia Scale-Revised (HDS-R), Immunoglobulin G (IgG), Interleukin (IL), Mild cognitive impairment (MCI), Mini-Mental State Examination (MMSE), National Health and Nutrition Examination Survey (NHAHES), Next- generation sequencing (NGS), Periodontal inflammation (PI), Polymerase chain reaction (PCR), Raven’s Coloured Progressive Matrices (RCPM), Subjective cognitive decline (SCD), Verbal Paired Associates (VerPA), Visual Paired Associates (VisPA)